Clinical Trial Update: Treatment of Schizoaffective Disorder Using Mifepristone [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating mifepristone for schizoaffective disorder was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Schizoaffective Disorder

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Stanford University | Conditions: Psychotic Disorders, Depressive Disorder, Major | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2017-03-24